Peking University Shenzhen Hospital

Obstetrics and Gynaecology Centre

Obstetrics and Gynecology is a discipline under the Guangdong Province High-Level Hospital Construction Program, a Guangdong Provincial Clinical Key Specialty Construction Unit (Gynecology), a Shenzhen Key Discipline in Gynecology (new round), a doctoral and master’s graduate training site of Peking University, a postdoctoral workstation of the Shenzhen Peking University–Hong Kong University of Science and Technology Medical Center, a National “Demonstration Base for Early Diagnosis and Early Treatment of Cervical Cancer,” a Shenzhen Key Laboratory of Early Diagnosis Technology for Major Female Diseases, the Shenzhen Gynecological Oncology Engineering Technology Research and Development Center, the dual-chair institution of the “Fertility Preservation Branch of the Chinese Preventive Medicine Association” and the “Professional Committee for Fertility Preservation of the Chinese Anti-Cancer Association,” a Guangdong Provincial Featured Specialty Construction Unit for Maternal and Perinatal Health Care, and the Shenzhen Maternal and Obstetric Treatment Center. It was among the first batch of pilot units nationwide to undertake the clinical application of prenatal screening and diagnosis using high-throughput gene sequencing. The Obstetrics and Gynecology Center has an outpatient department, Gynecology Ward 1, Gynecology Ward 2, a combined obstetrics and gynecology ward, Obstetrics Ward 1, a delivery room, and an obstetric homelike ward, with 180 beds in operation. It has nearly 14,000 inpatient visits annually and more than 10,000 inpatient surgeries/deliveries annually; it has specialty outpatient clinics for gynecologic oncology, fertility preservation, cervical lesions, endometrial lesions, gynecologic endocrinology, reproductive surgery, pelvic floor diseases, and gynecologic inflammation, as well as a general gynecology outpatient clinic, with nearly 1,000 outpatient visits per day on average. The Center has subspecialties including gynecologic oncology, female pelvic floor dysfunction, female reproductive endocrinology and reproductive surgery, maternal-fetal medicine, and pathological obstetrics. It widely provides diagnosis and treatment for various benign and malignant gynecologic tumors, with particular emphasis on fertility preservation for benign and malignant gynecologic diseases, comprehensive treatment of malignant diseases, excision of lesions in diffuse cervical lesions, uterine reconstruction, and technologies such as “ovarian cryopreservation + oocyte cryopreservation” for patients with various tumors. Over the past five years, the Department of Obstetrics and Gynecology has undertaken more than 20 research projects, with total research funding exceeding 40 million; it has published more than 160 papers in domestic and international journals, including 80 papers indexed by SC; it has carried out more than 10 cutting-edge new technology projects, some at advanced international and domestic levels, and completed dozens of research projects at various levels and international collaborative studies. “Establishment and Application of a Population Cervical Cancer Screening Model Based on Self-Sampling HPV Testing” won the second prize of the 2017 Huaxia Medical Science and Technology Award. Three papers on research into colposcopic cervical lesions were cited by the 2017 US ASCCP Standard Practice Guidelines for Colposcopy, and the self-sampling HPV testing-based cervical cancer screening model was selected as one of the “Top Ten Medical Innovations Affecting the Future of Humanity” in 2017. “Construction and Large-Scale Population Promotion and Application of an Innovative Cervical Cancer Prevention and Control System” won the second prize of the 2019 Chinese Preventive Medicine Association Science and Technology Award. In 2020, the Obstetrics and Gynecology discipline was approved as a Class A “Peak Discipline” under the Guangdong Province High-Level Hospital Construction Program; in 2022, it was included in the “14th Five-Year Plan for the Development of Shenzhen’s Health and Wellness Undertaking” issued by the Shenzhen Municipal People’s Government, under the key project “Key Discipline Group Construction Project.” Since 2015, it has ranked among the nation’s top 100 disciplines for nine consecutive years. It ranked 43rd in the 2022 China Hospital Science and Technology Influence Specialty Ranking (No. 1 in Shenzhen). It ranked 45th in the 2023 China Hospital Science and Technology Influence Specialty Ranking (No. 1 in Shenzhen).